CDRT15P12

Across TCGA pan-cancer cohorts, CDRT15P12 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated CDRT15P12 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher CDRT15P12 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CDRT15P12 expression acts as an unfavorable survival marker, although some lineages such as LUSC and BRCA show a favorable association.

LUSC, KIRC, and BRCA are the cancer types where CDRT15P12 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.848	0.746	.003	44	view →
KIRC	DFS	Median	III,IV	0.365	0.573	.001	43	view →
BRCA	OS	Tertile	All	0.678	0.515	.003	42	view →
HNSC	OS	Median	IV	0.681	0.527	.003	39	view →
OV	OS	Median	All	0.741	0.633	.003	34	view →
LGG	OS	Tertile	All	0.931	0.853	.001	31	view →
UCEC	DFS	Quartile	IV	0.973	0.544	.008	26	view →
UCS	DFS	Tertile	IV	0.996	0.401	.024	24	view →
COAD	OS	Tertile	IV	0.258	0.644	.006	20	view →
STAD	DFS	Tertile	III,IV	0.738	0.443	.005	12	view →
THCA	OS	Median	All	0.959	0.990	.015	10	view →
CESC	OS	Median	All	0.908	0.835	.014	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

CDRT15P12–LUSC (OS)

Open the LUSC breakdown →